- IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price
- Shadow Work: How Businesses Are Turning Us All Into Unpaid Laborers
- Boomers' Biggest Retirement Regret? They Didn't Work Longer
- Carnival CEO Aims to Bust the Biggest Myths About the Cruise Industry
- The 10 Poorest States in America
All central banks attempt to avoid deflation like the plague. But why exactly is it so detrimental and how can it affect your investments?
AcelRx shareholders were burned yet again when the company announced new clinical trials were required for its flagship drug. What's to come for this struggling biotech company?
The U.S. dollar has been one of the best performing currencies within the last year, but what has catalyzed this strength and will it continue?
A negative-yield bond literally means you are paying a government for the right to loan them money. What's the logic behind owning such a counterintuitive investment?
There should be no alterations in oil policy from Saudi Arabia, but be cognizant of any cabinet changes, specifically oil minister Al-Naimi.
AcelRx Pharmaceuticals was hit with an FDA rejection and is due to resubmit their drug this quarter; should investors stay away or is there an opportunity to be had?
Bullish on Cuba? A fund and some individual stocks you want to consider.
Plunging oil prices and the skidding ruble have wreaked havoc on the Russian economy, creating major worries in global markets.
The beneficiaries and those feeling the pain of declining oil prices aren't as straightforward as you think.
Maybe only for the short-term price of oil.